BMY 14802 is a sigma-1 receptor (sigma1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinsons disease (PD) model, with down-regulating the expression of AIM[1][2].
Molekulargewicht:
348.39
Reinheit:
98.96
CAS Nummer:
[105565-56-8]
Formel:
C18H22F2N4O
Target-Kategorie:
5-HT Receptor,Adrenergic Receptor,Sigma Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten